医药和生物技术领域的联合推广和联合行销协议（2016-2026）

本报告是分析生命科学产业联合商业化策略最全面的资源。报告包含 384 个详细的案例研究，并提供公开合约的连结。这份经过全面修订和更新的报告详细揭示了该行业最重要的合作关係的合约条款、结构和策略。

无论您是在洽谈新的合作关係，还是在评估现有合作关係，本报告都能提供数据驱动的洞察，帮助您建立更聪明、更强大、更获利的协议。

您将从本报告中获得：

• 取得 384 个真实案例：详细了解合约结构、收益分成、地理划分和商业化责任，并提供线上合约文件的连结（如有）。
• 了解成功的合约结构：了解生物製药行业的领导者如何在联合推广和联合行销协议中划分推广活动、分配权利和管理独家销售权。
• 自信谈判：利用详细的财务数据（包括付款条款）来了解标准和可行的条件。
• 向业界领导者学习：研究辉瑞、诺华和阿斯特捷利康等公司如何进行联合商业化。
• 查阅实际合约：审查实际合约（例如美国证券交易委员会 (SEC) 的文件），以了解新闻稿或资料库中未揭露的交易机制。
• 了解市场趋势：追踪市场活动，包括依年份、治疗领域、技术类型和公司（A-Z）划分的趋势。

目录

摘要整理

第一章：引言

第二章：共同推广与联合行销的趋势

• 共同推广与联合行销协议的定义
• 2016年以来的合约趋势
  • 依年份划分的合约趋势
  • 依研发阶段划分的合约趋势
  • 依行业划分的合约趋势
  • 依治疗领域划分的合约趋势
  • 依技术类型划分的合约趋势
  • 最活跃的公司合约趋势
• 签订合作协议的原因
• 共同推广与联合行销的未来协议

第三章：联合推广与联合行销协议的架构：概述

• 共同推广与联合行销协议的架构

第四章：主要联合推广与联合行销协议

• 主要共同推广与联合行销交易：依金额排序

第五章：最活跃的25个联合推广与联合行销合约

• 最活跃的25个联合推广和联合行销合约

第六章：联合推广与联合行销协议（含合约目录）

• 共同推广与联合行销协议： 2016-2026
• 合约目录
• 合约目录：依公司（A-Z）
• 合约目录：依治疗领域
• 合约目录：依技术
• 关于 Biopharma Research Ltd
• 当前合作伙伴关係
• 当前协议
• 近期合作报告标题

The Definitive Resource for Structuring and Benchmarking Shared Commercialization Partnerships

The Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2026 report provides the most comprehensive analysis available of co-commercialization strategies across the life sciences industry. Featuring 384 detailed deal records and links to publicly available contracts where filed, this fully revised and updated report gives you an unmatched look inside the terms, structures, and strategies behind the industry's most impactful partnerships.

Whether you're negotiating a new alliance or benchmarking existing agreements, this report gives you the data-driven insights you need to craft smarter, stronger, and more profitable deals.

What You'll Gain

• Access 384 Real-World Deals - Get the details on deal structure, revenue sharing, territory splits, and commercialization responsibilities, with links to online contract documents where available.
• Understand Winning Structures - See how biopharma leaders split promotional duties, allocate rights, and manage exclusivity across co-promotion and co-marketing agreements.
• Negotiate with Confidence - Leverage detailed financial data, including payment terms, to understand what's standard-and what's possible.
• Learn from the Leaders - Examine how top players like Pfizer, Novartis and AstraZeneca approach co-commercialization.
• Access Real Contracts - Where available, review actual SEC-filed agreements to understand deal mechanics that press releases and databases don't reveal.
• Stay Ahead of Market Trends - Track activity including trends by year, therapy area, technology type, and company A-Z.

Inside the Report - Chapter Overview

Chapter 1: Introduction

An orientation to the structure, purpose, and use of the report.

Chapter 2: Co-promotion and Co-marketing Trends

Covers key industry trends, growth in activity, and strategic rationale for shared commercialization models.

Chapter 3: Deal Structures and Terms

Explains how companies structure these partnerships-including revenue splits, territories, exclusivity, responsibilities, and duration.

Chapter 4: Top Deals by Value

A curated overview of high-value deals with direct links to online records and available SEC-filed contracts.

Chapter 5: Top 25 Most Active Dealmakers

Profiles of the most prolific companies in co-commercialization, each linked to their deal records and available contract documents.

Chapter 6: Deal Analysis by Company, Therapy & Tech

An in-depth review of all co-promotion and co-marketing deals signed since 2016, categorized by company A-Z, therapeutic area, technology type, and contract availability.

Deal Directory

A complete deal listing, each linked to a detailed record in the Current Agreements database, with direct access to contract documents where available.

What's Included

Industry trends in co-promotion and co-marketing (2016-2026)

Overview of deal structures and revenue models

Analysis of top deals and dealmakers

Directory of all deals by company, therapy area, and technology

Access to real contract documents (where publicly available)

Numerous tables and figures illustrating activity across the industry

Who Should Use This Report?

• Business Development & Licensing Teams - Evaluate deal structures and identify ideal partners.
• Commercial Strategy & Operations - Plan smarter co-launches and regional strategies.
• Legal & Contracts Teams - Benchmark clauses and strengthen negotiation positions with real contract language.
• C-Level Executives & Investors - Assess monetization strategies and partnership dynamics in commercial-stage assets.

Due Diligence Made Easy: What You'll Learn from Contracts

By reviewing actual deal agreements, you can evaluate key aspects such as:

• What rights are granted or optioned?
• How is revenue shared and audited?
• What exclusivity and territory provisions are included?
• Who handles commercialization, manufacturing, and supply?
• What is the term and how is termination managed?
• How are disputes, confidentiality, and publication handled?
• Which legal jurisdiction is used?
• Are sublicensing and subcontracting allowed?
• Which clauses are standardized, and which vary across partners?
• Why This Report Matters
• Co-promotion and co-marketing strategies have become vital for maximizing commercial potential, especially in competitive or specialty-driven markets. This report delivers critical intelligence on how industry leaders are structuring these deals-giving you a clear path to negotiate better terms, avoid common pitfalls, and select the right partners.
• Get ahead of your next deal. Explore the data. Learn from the contracts. Make better decisions.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2016
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2026
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2026
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2026
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2026
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2026
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2026
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2016-2026
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2016-2026
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2016-2026
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2016-2026
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2016-2026
• Figure 6: Co-promotion and co-marketing deals by technology type, 2016-2026
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2016-2026
• Figure 8: Top co-promotion and co-marketing deals by value, 2016-2026
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2016-2026